According to EZZ Life Science Holdings latest financial reports the cash on hand of EZZ is $9.36M, an increase of 32.16% to 2022. At the end of 2022 company had $7.08M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $9.36M | 32.16% |
2022 | $7.08M | 18.20% |
2021 | $5.99M | 5.31% |
2020 | $5.69M | - |